Nocturne 630% funded on Kickstarter in first 36 hours
OAKLAND, Calif., May 1, 2025 /PRNewswire/ — Measure Things LLC has successfully launched Nocturne on Kickstarter. Nocturne is unique in its ability to fine-tune generic noise and natural sounds, enabling users to better tune out distractions, from high-pitched tinnitus to the low rumble of noisy neighbors.
With over $63,000 raised on Kickstarter in the first 36 hours, Nocturne is now preparing for production. It is set to ship later this year.
“Nocturne originated as a tool to manage my own tinnitus, and is something that I hope can help others get the rest and focus they need, regardless of what keeps them distracted and awake,” says founder Russell Warriner. “We are beyond excited about the initial reception.“
Key product features:
Even though Nocturne was designed to help with tinnitus, the company has heard from early backers who want to use the product to manage insomnia, focus at work, mask confidential conversations, and add to their bedroom or office aesthetic, among other things.
Nocturne is available on Kickstarter until May 28 at discounted prices. It will be available on regular e-commerce channels later this year.
About
Measure Things LLC makes purposeful, beautiful devices that are carefully designed to be easy to use and extremely good at what they do. The company was founded by ex-Apple employee Russell Warriner, and is headquartered in Oakland, California.
Contact
Russell Warriner, Founder and CEO
contact@nocturne.shop
nocturne.shop
SOURCE Measure Things LLC
New initiative will promote AI policies and solutions to transform American health careWASHINGTON, Jan. 12,…
Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA…
GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…
Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…
Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at…